title: Fragile X-associated tremor/ataxia syndrome presenting in a woman after chemotherapy.
authors.affiliation: Department of Neurology, St. Vincent's University Hospital, Dublin 4, Ireland. drjpodwyer@eircom.net
authors.forename: J P
authors.initials: JP
authors.lastname: O'Dwyer
authors.forename: C
authors.initials: C
authors.lastname: Clabby
authors.forename: J
authors.initials: J
authors.lastname: Crown
authors.forename: D E
authors.initials: DE
authors.lastname: Barton
authors.forename: M
authors.initials: M
authors.lastname: Hutchinson
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001284:Atrophy / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016190:Carboplatin / Q000009:adverse effects; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary; D002524:Cerebellar Ataxia / Q000139:chemically induced* / Q000235:genetics* / Q000503:physiopathology; D002531:Cerebellum / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D004351:Drug Resistance / Q000235:genetics; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics; D005600:Fragile X Syndrome / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008279:Magnetic Resonance Imaging
chemical_list: D016190:Carboplatin; D051860:Fragile X Messenger Ribonucleoprotein 1; C497683:FMR1 protein, human